ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2023-06, Vol.41 (S2), p.141-142 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 142 |
|---|---|
| container_issue | S2 |
| container_start_page | 141 |
| container_title | Hematological oncology |
| container_volume | 41 |
| creator | Poon, M. Walewski, J. Kim, T. M. Cho, S. Jarque, I. Iskierka‐Jażdżewska, E. Prince, H. M. Oh, S. Y. Lim, F. Carpio, C. Tan, T. Ayyappan, S. Gutierrez, A. Li, J. Ufkin, M. Zhu, M. Chaudhry, A. Mohamed, H. Ambati, S. Kim, W. S. |
| description | |
| doi_str_mv | 10.1002/hon.3163_93 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3089983189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089983189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1873-5ee818ff560b4a96c8fcca435d85548d892dbde7a77f0907e5f2ed7bf278f22d3</originalsourceid><addsrcrecordid>eNp9kc9q3DAQxkVpoNukp76AoJeW4kR_1mupN60txwLZMra37Z6E15ZoQpJN7YaSWx4hL9EX65NEYXPOZYaP-c03MB8AHzE6xQiRs1_7m1OKV9Ry-gYsMOI8wmjF34IFIgmLEKHkHXg_z5cIhRliC_DPZI2p5M9OlGINVQVr0SlZdS38oboCNlKLupXZWSPzRqSdabYwU3m-aSXUojmXcP3_4TGVWkO9LevClAJ-zvQ61V--heV2o4NT3pgSClgHXctU5UpmUFRCb1vVQpPDrpCwVt9NJzSsCxGslYJtt8m2UOoy-JMTcOT7q9l9eOnHYJPLLi0ibc5VKnQ0YJbQKHaOYeZ9vEK7Zc9XA_PD0C9pPLI4XrKRcTLuRpf0SeIRR4mLPXFjsvPhOZ6QkR6DTwff22n_-87Nf-zl_m66CSctRYxzRjHjgfp6oIZpP8-T8_Z2urjup3uLkX3OwYYc7EsOgaYH-u_Flbt_DbWFqUJ9VvQJnWKAkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089983189</pqid></control><display><type>article</type><title>ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2</title><source>Access via Wiley Online Library</source><creator>Poon, M. ; Walewski, J. ; Kim, T. M. ; Cho, S. ; Jarque, I. ; Iskierka‐Jażdżewska, E. ; Prince, H. M. ; Oh, S. Y. ; Lim, F. ; Carpio, C. ; Tan, T. ; Ayyappan, S. ; Gutierrez, A. ; Li, J. ; Ufkin, M. ; Zhu, M. ; Chaudhry, A. ; Mohamed, H. ; Ambati, S. ; Kim, W. S.</creator><creatorcontrib>Poon, M. ; Walewski, J. ; Kim, T. M. ; Cho, S. ; Jarque, I. ; Iskierka‐Jażdżewska, E. ; Prince, H. M. ; Oh, S. Y. ; Lim, F. ; Carpio, C. ; Tan, T. ; Ayyappan, S. ; Gutierrez, A. ; Li, J. ; Ufkin, M. ; Zhu, M. ; Chaudhry, A. ; Mohamed, H. ; Ambati, S. ; Kim, W. S.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3163_93</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma</subject><ispartof>Hematological oncology, 2023-06, Vol.41 (S2), p.141-142</ispartof><rights>2023 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1873-5ee818ff560b4a96c8fcca435d85548d892dbde7a77f0907e5f2ed7bf278f22d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.3163_93$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.3163_93$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Poon, M.</creatorcontrib><creatorcontrib>Walewski, J.</creatorcontrib><creatorcontrib>Kim, T. M.</creatorcontrib><creatorcontrib>Cho, S.</creatorcontrib><creatorcontrib>Jarque, I.</creatorcontrib><creatorcontrib>Iskierka‐Jażdżewska, E.</creatorcontrib><creatorcontrib>Prince, H. M.</creatorcontrib><creatorcontrib>Oh, S. Y.</creatorcontrib><creatorcontrib>Lim, F.</creatorcontrib><creatorcontrib>Carpio, C.</creatorcontrib><creatorcontrib>Tan, T.</creatorcontrib><creatorcontrib>Ayyappan, S.</creatorcontrib><creatorcontrib>Gutierrez, A.</creatorcontrib><creatorcontrib>Li, J.</creatorcontrib><creatorcontrib>Ufkin, M.</creatorcontrib><creatorcontrib>Zhu, M.</creatorcontrib><creatorcontrib>Chaudhry, A.</creatorcontrib><creatorcontrib>Mohamed, H.</creatorcontrib><creatorcontrib>Ambati, S.</creatorcontrib><creatorcontrib>Kim, W. S.</creatorcontrib><title>ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2</title><title>Hematological oncology</title><subject>Lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kc9q3DAQxkVpoNukp76AoJeW4kR_1mupN60txwLZMra37Z6E15ZoQpJN7YaSWx4hL9EX65NEYXPOZYaP-c03MB8AHzE6xQiRs1_7m1OKV9Ry-gYsMOI8wmjF34IFIgmLEKHkHXg_z5cIhRliC_DPZI2p5M9OlGINVQVr0SlZdS38oboCNlKLupXZWSPzRqSdabYwU3m-aSXUojmXcP3_4TGVWkO9LevClAJ-zvQ61V--heV2o4NT3pgSClgHXctU5UpmUFRCb1vVQpPDrpCwVt9NJzSsCxGslYJtt8m2UOoy-JMTcOT7q9l9eOnHYJPLLi0ibc5VKnQ0YJbQKHaOYeZ9vEK7Zc9XA_PD0C9pPLI4XrKRcTLuRpf0SeIRR4mLPXFjsvPhOZ6QkR6DTwff22n_-87Nf-zl_m66CSctRYxzRjHjgfp6oIZpP8-T8_Z2urjup3uLkX3OwYYc7EsOgaYH-u_Flbt_DbWFqUJ9VvQJnWKAkQ</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Poon, M.</creator><creator>Walewski, J.</creator><creator>Kim, T. M.</creator><creator>Cho, S.</creator><creator>Jarque, I.</creator><creator>Iskierka‐Jażdżewska, E.</creator><creator>Prince, H. M.</creator><creator>Oh, S. Y.</creator><creator>Lim, F.</creator><creator>Carpio, C.</creator><creator>Tan, T.</creator><creator>Ayyappan, S.</creator><creator>Gutierrez, A.</creator><creator>Li, J.</creator><creator>Ufkin, M.</creator><creator>Zhu, M.</creator><creator>Chaudhry, A.</creator><creator>Mohamed, H.</creator><creator>Ambati, S.</creator><creator>Kim, W. S.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202306</creationdate><title>ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2</title><author>Poon, M. ; Walewski, J. ; Kim, T. M. ; Cho, S. ; Jarque, I. ; Iskierka‐Jażdżewska, E. ; Prince, H. M. ; Oh, S. Y. ; Lim, F. ; Carpio, C. ; Tan, T. ; Ayyappan, S. ; Gutierrez, A. ; Li, J. ; Ufkin, M. ; Zhu, M. ; Chaudhry, A. ; Mohamed, H. ; Ambati, S. ; Kim, W. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1873-5ee818ff560b4a96c8fcca435d85548d892dbde7a77f0907e5f2ed7bf278f22d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poon, M.</creatorcontrib><creatorcontrib>Walewski, J.</creatorcontrib><creatorcontrib>Kim, T. M.</creatorcontrib><creatorcontrib>Cho, S.</creatorcontrib><creatorcontrib>Jarque, I.</creatorcontrib><creatorcontrib>Iskierka‐Jażdżewska, E.</creatorcontrib><creatorcontrib>Prince, H. M.</creatorcontrib><creatorcontrib>Oh, S. Y.</creatorcontrib><creatorcontrib>Lim, F.</creatorcontrib><creatorcontrib>Carpio, C.</creatorcontrib><creatorcontrib>Tan, T.</creatorcontrib><creatorcontrib>Ayyappan, S.</creatorcontrib><creatorcontrib>Gutierrez, A.</creatorcontrib><creatorcontrib>Li, J.</creatorcontrib><creatorcontrib>Ufkin, M.</creatorcontrib><creatorcontrib>Zhu, M.</creatorcontrib><creatorcontrib>Chaudhry, A.</creatorcontrib><creatorcontrib>Mohamed, H.</creatorcontrib><creatorcontrib>Ambati, S.</creatorcontrib><creatorcontrib>Kim, W. S.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poon, M.</au><au>Walewski, J.</au><au>Kim, T. M.</au><au>Cho, S.</au><au>Jarque, I.</au><au>Iskierka‐Jażdżewska, E.</au><au>Prince, H. M.</au><au>Oh, S. Y.</au><au>Lim, F.</au><au>Carpio, C.</au><au>Tan, T.</au><au>Ayyappan, S.</au><au>Gutierrez, A.</au><au>Li, J.</au><au>Ufkin, M.</au><au>Zhu, M.</au><au>Chaudhry, A.</au><au>Mohamed, H.</au><au>Ambati, S.</au><au>Kim, W. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2</atitle><jtitle>Hematological oncology</jtitle><date>2023-06</date><risdate>2023</risdate><volume>41</volume><issue>S2</issue><spage>141</spage><epage>142</epage><pages>141-142</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.3163_93</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2023-06, Vol.41 (S2), p.141-142 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_3089983189 |
| source | Access via Wiley Online Library |
| subjects | Lymphoma |
| title | ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ODRONEXTAMAB%20IN%20PATIENTS%20WITH%20RELAPSED/REFRACTORY%20DIFFUSE%20LARGE%20B%E2%80%90CELL%20LYMPHOMA%20(DLBCL):%20RESULTS%20FROM%20A%20PRESPECIFIED%20ANALYSIS%20OF%20THE%20PIVOTAL%20PHASE%20II%20STUDY%20ELM%E2%80%902&rft.jtitle=Hematological%20oncology&rft.au=Poon,%20M.&rft.date=2023-06&rft.volume=41&rft.issue=S2&rft.spage=141&rft.epage=142&rft.pages=141-142&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3163_93&rft_dat=%3Cproquest_cross%3E3089983189%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3089983189&rft_id=info:pmid/&rfr_iscdi=true |